Current status of pediatric human immunodeficiency virus infection in Japan

被引:0
|
作者
Sunohara, Daisuke [1 ]
Nishimata, Shigeo [1 ]
Kondo, Atsushi [1 ]
Ishii, Chiako [1 ]
Kashiwagi, Yasuyo [1 ]
Kawashima, Hisashi [1 ]
机构
[1] Tokyo Med Univ, Dept Pediat, Shinjuku Ku, Tokyo 1600023, Japan
关键词
Pediatric HIV; AIDS; Co-infection; Mother-to-child transmission; TO-CHILD TRANSMISSION; HEPATITIS-C; HIV-1-INFECTED CHILDREN; DISEASE PROGRESSION; HIV; LIVER; COHORT; HCV;
D O I
10.1016/j.jiac.2014.07.019
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There are currently very few English reports about Japanese pediatric human immunodeficiency virus (HIV). In this study, we introduce our experience with pediatric HIV in a single hospital, and review the present status of HIV infections in children in Japan. In Japan, the main infection routes of HIV include sexual activity, mother-to-child transmission (MTCT), blood or blood product transfusion, and drug use. Most pediatric HIV patients have been infected by MTCT in recent years. One survey showed that in Japan, 52 babies were infected by MTCT between 1984 and 2011. Only 2 cases of pediatric HIV infection have been reported since 2010. The MTCT rate has decreased to 0.5% owing to several preventive interventions. In addition, the HIV antibody test is now performed in more than 98.3% of pregnant women in Japan. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:661 / 665
页数:5
相关论文
共 50 条
  • [31] CD28 Expression in Pediatric Human Immunodeficiency Virus Infection
    Tim Niehues
    Jennifer Ndagijimana
    Gerd Horneff
    Volker Wahn
    Pediatric Research, 1998, 44 : 265 - 268
  • [32] PEDIATRIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN A LOW SEROPREVALENCE AREA
    PRATT, RD
    HATCH, R
    DANKNER, WM
    SPECTOR, SA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (04) : 304 - 310
  • [33] Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection
    Grub, S
    DeLora, P
    Lüdin, E
    Duff, F
    Fletcher, CV
    Brundage, RC
    Kline, MW
    Calles, NR
    Schwarzwald, H
    Jorga, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) : 122 - 130
  • [34] PRIORITIES IN PSYCHOSOCIAL RESEARCH IN PEDIATRIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    JANSEN, JK
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1994, 15 (03): : S3 - S4
  • [35] ENHANCED LV FUNCTION IN PEDIATRIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    LIPSHULTZ, SE
    SANDERS, SP
    COLAN, SD
    MCINTOSH, K
    PEDIATRIC RESEARCH, 1989, 25 (04) : A183 - A183
  • [36] CD28 expression in pediatric human immunodeficiency virus infection
    Niehues, T
    Ndagijimana, J
    Horneff, G
    Wahn, V
    PEDIATRIC RESEARCH, 1998, 44 (02) : 265 - 268
  • [38] EPIDEMIOLOGIC CHARACTERISTICS ON HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN JAPAN
    MIYAZAKI, M
    NAEMURA, M
    INTERNATIONAL JOURNAL OF STD & AIDS, 1994, 5 (04) : 273 - 278
  • [39] Predictors of change in the functional status of children with human immunodeficiency virus infection
    Missmer, SA
    Spiegelman, D
    Gorbach, SL
    Miller, TL
    PEDIATRICS, 2000, 106 (02) : E24
  • [40] The Current Status in Terms of Vaccination for Individuals Infected with Human Immunodeficiency Virus
    Xu, Nan
    Shen, Yanru
    Huang, Weijin
    Nie, Jianhui
    VIRUSES-BASEL, 2025, 17 (02):